Velo3D (NASDAQ: VELO) posts Q1 2026 growth, trims losses and cuts debt
Rhea-AI Filing Summary
Velo3D, Inc. reported much stronger first-quarter 2026 results, with revenue of $13.8 million, up 48% from $9.3 million a year earlier, and gross margin improving to 17.2% from 7.5%. The GAAP net loss narrowed to $7.0 million (or $0.28 per share) versus $25.0 million ($1.87 per share) in the prior-year quarter, while non-GAAP net loss improved to $5.1 million from $9.0 million.
Adjusted EBITDA loss improved to $(3.6) million from $(6.9) million, and operating expenses fell to $9.3 million from $12.2 million, reflecting tighter cost control. The company ended March 31, 2026 with $16.6 million of cash and cash equivalents, $30 million of backlog, and $12 million in new bookings.
Velo3D highlighted a $9.8 million, five-year IDIQ contract with the Defense Logistics Agency and closed an April 2026 underwritten registered direct equity offering of 3,571,428 shares for approximately $50 million in gross proceeds. Management reiterated full-year 2026 guidance for revenue of $60–$70 million, gross margin above 30% in the second half, non-GAAP adjusted operating expenses of $45–$55 million, capital expenditures of $40–$50 million, and a goal of positive EBITDA in the second half of 2026.
Positive
- Q1 2026 financial improvement: Revenue rose 48% year-over-year to $13.8 million, gross margin turned positive at 17.2% versus 7.5%, and GAAP net loss narrowed sharply to $7.0 million from $25.0 million, indicating better scaling and cost control.
- Capital raise and de-leveraging: In April 2026 the company raised approximately $50 million of gross proceeds via an underwritten registered direct equity offering and completed $15 million of debt-to-equity conversions plus full secured note repayment, reducing outstanding debt to about $9 million.
- Defense contract and backlog: A $9.8 million, five-year IDIQ contract with the Defense Logistics Agency supports the JAMA Pilot Parts Program, while new bookings of $12 million and $30 million of ending backlog provide visibility for near-term demand.
Negative
- Ongoing losses and cash burn: Despite improvement, the company reported a Q1 2026 GAAP net loss of $7.0 million, adjusted EBITDA of negative $3.6 million, and used $18.0 million of cash in operating activities, contributing to cash and equivalents declining to $16.6 million at quarter-end.
- High capital needs and planned spending: Management projects 2026 non-GAAP adjusted operating expenses of $45–$55 million and capital expenditures of $40–$50 million, primarily for RPS expansion, which are explicitly noted as subject to the availability of sufficient financing.
Insights
Velo3D shows sharp revenue growth, margin turnaround, and major de-leveraging, but still burns cash.
Velo3D delivered Q1 2026 revenue of $13.8M, up 48% year-over-year, with gross margin improving to 17.2% from 7.5%. Net loss shrank to $7.0M, and adjusted EBITDA loss improved to $(3.6M) from $(6.9M), signaling better unit economics and cost discipline.
The balance sheet changed meaningfully. Cash and equivalents were $16.6M on March 31, 2026, down from $39.0M at year-end, but the company then raised about $50M in an April equity offering and executed $15M of debt-to-equity conversions, cutting debt roughly 70% to about $9M. This combination reduces financial leverage but introduces equity dilution.
Management reaffirmed 2026 guidance: revenue of $60–$70M, gross margin above 30% in the second half, non-GAAP operating expenses of $45–$55M, capex of $40–$50M, and a target of positive EBITDA in the second half of 2026. Achieving these goals depends on converting a $30M backlog and new defense and aerospace demand, including a $9.8M DLA IDIQ contract, into timely shipments while controlling spending.
8-K Event Classification
Key Figures
Key Terms
Adjusted EBITDA financial
Indefinite Delivery Indefinite Quantity (IDIQ) financial
Non-GAAP net loss financial
backlog financial
registered direct offering financial
Non-GAAP Adjusted Operating Expenses financial
Earnings Snapshot
For full-year 2026, Velo3D expects revenue of $60–$70 million, gross margin above 30% in the second half, non-GAAP adjusted operating expenses of $45–$55 million, capital expenditures of $40–$50 million, and positive EBITDA in the second half of 2026.
|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
|
FORM
|
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
|
|
(Exact name of registrant as specified in its charter)
|
|
|||
(State or other jurisdiction of incorporation) |
|
(Commission File Number) |
|
(IRS Employer Identification No.) |
|
|
||
|
|||
(Address of principal executive offices) |
|
(Zip Code) |
|
Registrant’s telephone number, including area code
N/A
(Former name or former address, if changed since last report.)
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
|
Item 2.02 Results of Operations and Financial Condition.
On May 12, 2026, Velo3D, Inc. (the “Company”) issued a press release announcing its financial results for the three months ended March 31, 2026 (the "Press Release"). In the Press Release, the Company also announced that it would be holding a conference call on May 12, 2026 at 2:00 p.m. Pacific Time to discuss its financial results for the three months ended March 31, 2026.
Item 7.01 Regulation FD Disclosure.
On May 12, 2026, the Company also published earnings presentation slides (the "Earnings Presentation") related to its financial results for the three months ended March 31, 2026 for use in investor discussions. Copies of the Press Release and Earnings Presentation are furnished as Exhibits 99.1 and 99.2, respectively, to this Current Report on Form 8-K.
The information furnished with this Item 2.02 and Item 7.01, including Exhibits 99.1 and 99.2, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Item 9.01. Financial Statement and Exhibits.
(d) Exhibits.
Exhibit Number |
|
Description |
99.1 |
|
Press Release, dated May 12, 2026, regarding the Registrant’s results for the quarter ended March 31, 2026 |
99.2 |
|
Earnings Presentation, dated May 12, 2026 |
104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
Velo3D, Inc. |
|
|
|
|
|
|
Date: |
May 12, 2026 |
|
By: |
/s/ James Suva |
|
|
|
Name: |
James Suva |
|
|
|
Title: |
Chief Financial Officer |
Exhibit 99.1
Velo3D Announces First Quarter 2026 Financial Results
FREMONT, Calif., May 12, 2026- Velo3D, Inc. (Nasdaq: VELO) (“Velo3D” or the “Company”), a leader in additive manufacturing (“AM”) technology known for transforming aerospace and defense supply chains through world-class metal AM, today announced financial results for its first quarter ended March 31, 2026.
Recent Business Developments
“For the first quarter, we delivered a strong start to 2026 with revenue up 48% year‑over‑year, reflecting recent sales momentum and disciplined execution across our end markets,” said Arun Jeldi, CEO of Velo3D. “Importantly, we achieved positive gross margin this quarter, a key inflection point that validates our operating model as we scale production and continue to drive cost efficiency. With a robust pipeline of opportunities, we believe we have a solid foundation for continued growth.”
“Demand remains particularly strong in defense and aerospace, where customers are prioritizing scalable, high‑performance additive manufacturing solutions. To support this demand and accelerate our expansion, we completed a successful equity offering in April, securing additional capital to invest in talent and operational infrastructure. We believe our competitive position is strengthening as we deepen customer relationships and expand into new programs. We remain focused on executing our expansion plans to capture these opportunities and drive long‑term value creation.”
($ in Millions, except percentages and per-share data) |
1st Quarter 2026 |
1st Quarter 2025 |
GAAP revenue |
$13.8 |
$9.3 |
GAAP gross margin |
17.2 % |
7.5 % |
GAAP net loss1 |
($7.0) |
($25.0) |
GAAP net loss per share – basic and diluted |
($0.28) |
($1.87) |
|
|
|
Non-GAAP net loss1,2 |
($5.1) |
($9.0) |
Non-GAAP net loss per share – basic and diluted1,2 |
($0.20) |
($0.67) |
Summary of First Quarter 2026 Results
Total Revenue was $13.8 million. 3D Printer and parts revenue increased 60% compared to the first quarter of 2025, driven by an increase in the average selling price, number of systems sold, and an increase in RPS revenues. While system sales are expected to remain the primary driver of revenue in 2026, the Company anticipates that, under its new go-to-market strategy, its RPS parts production business will contribute an increasing share of revenue.
Gross margin for the first quarter was 17.2% compared to 7.5% in the first quarter of 2025. This change was primarily driven by the higher average selling price of Sapphire XC systems and increased RPS volume.
Operating expenses for the first quarter were $9.3 million compared to $12.2 million in the first quarter of 2025. Non-GAAP adjusted operating expenses, excluding stock-based compensation recorded in operating expenses of $1.2 million, were $8.1 million, down from $8.8 million in the first quarter of 2025.
GAAP net loss for the first quarter was ($7.0) million compared to ($25.0) million in the first quarter of 2025. Non-GAAP net loss for the first quarter was ($5.1) million compared to ($9.0) million in the three months ended March 31, 2025. Adjusted EBITDA for the first quarter was ($3.6) million compared to ($6.9) million in the first quarter of 2025. For more information regarding the Company’s non-GAAP financial measures, see “Non-GAAP Financial Information” below.
As of March 31, 2026, the Company had $16.6 million of cash and cash equivalents, compared to $39.0 million as of December 31, 2025. As of March 31, 2026, the Company had $12 million in new bookings and ending backlog of $30 million.
“On April 27, 2026, the Company closed a firm commitment underwritten registered direct offering of 3,571,428 shares of its common stock, with gross proceeds of approximately $50 million,” said Jim Suva, CFO of Velo3D. “During the first quarter of 2026, the Company also completed debt-to-equity conversions totaling principal of $15 million, including $5 million converted at a premium to the Company's share price on the date of conversion, and full repayment of the secured notes. As a result, we reduced our outstanding debt by approximately 70% to approximately $9 million.”
Guidance
Management reiterates expectations for the full year 2026 to include:
Conference Call
The Company will host a conference call for investors to discuss its first quarter 2026 financial results at 5 p.m. Eastern time / 2 p.m. Pacific time on May 12, 2026. The call will be webcast and can be accessed from the Events page of the Investor Relations section of Velo3D’s website at ir.velo3d.com.
About Velo3D:
Velo3D is a metal 3D printing technology company that enables customers to build mission-critical metal parts. The fully integrated solution includes the Flow print preparation software, the Sapphire® family of printers, and the Assure quality control system—all of which are powered by Velo3D's Intelligent Fusion® manufacturing process.
###
Investor Relations:
Velo3D
Hayden IR
James Carbonara, Managing Director
investors@velo3d.com
Media Contact:
Velo3D
press@velo3d.com
Amounts herein pertaining to the Company’s first quarter ended March 31, 2026 results represent a preliminary estimate as of the date of this earnings release and may be revised upon filing of our Quarterly Report on Form 10-Q with the U.S. Securities and Exchange Commission (the “SEC”). Additional information on our results of operations for the three months ended March 31, 2026 will be provided upon the filing of our Quarterly Report on Form 10-Q with the SEC.
Forward-Looking Statements:
This press release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. The Company’s actual results may differ from its expectations, estimates and projections and consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect”, “estimate”, “project”, “budget”, “forecast”, “anticipate”, “intend”, “plan”, “may”, “will”, “could”, “should”, “believes”, “predicts”, “potential”, “continue”, and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, the Company's guidance for fiscal year 2026 (including the Company’s estimates for revenue, gross margin, operating expenses, and capital expenditures), the Company’s expectations regarding its ability to achieve positive EBITDA in the second half of 2026, the Company’s expectations about future demand, growth, profitability, long-term value, capacity requirements and operational efficiencies, scaled production, pipeline of opportunities, customer priorities, positive gross margins, the Company’s expectations regarding its liquidity and capital requirements, including plans to raise additional capital to support its expansion and the potential sources and uses of that capital, the Company’s expectations regarding its potential cost savings, the Company’s expectations about its market strategy and financial and operational position, the Company's expectations that the RPS parts production business will contribute an increasing share of revenue, and the Company’s other expectations, beliefs, intentions or strategies for the future. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. You should carefully consider the risks and uncertainties described in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the “FY 2025 10-K”) and its Quarterly Reports on Form 10-Q ("Quarterly Reports") and the other documents filed by the Company from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Most of these factors are outside the Company’s control and are difficult to predict. Factors that may cause such differences include, but are not limited to: (1) the inability of the Company to execute its business plan, which may be affected by, among other things, competition, the Company’s liquidity position/lack of available cash, the ability of the Company to grow and manage growth profitably, maintain relationships with customers and suppliers and retain its key employees; (2) the Company’s ability to continue as a going concern; (3) the Company’s ability to service and comply with its indebtedness; (4) the Company’s ability to raise additional capital in the near-term; (5) the possibility that the Company may be adversely affected by other economic, business, and/or competitive factors; (6) changes in the applicable laws and regulations; (7) risks related to the Company’s exposure to government and defense contracts, including potential delays or reductions in government funding, government shutdowns, changes in defense procurement priorities or spending levels, and the timing and uncertainty of government contract awards and modifications; and (8) other risks and uncertainties described in the FY 2025 10-K and the Quarterly Reports, including those under “Risk Factors” therein, and in the Company’s other filings with the SEC. The Company cautions that the foregoing list of factors is not exclusive and not to place undue reliance upon any forward-looking statements, including projections, which speak only as of the date made. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by applicable law.
Non-GAAP Financial Information
The information in the table below sets forth the non-GAAP financial measures that the Company uses in this release. Because of the inherent limitations associated with these non-GAAP financial measures, “Non-GAAP Net Loss”, “Non-GAAP net loss per basic and diluted share”, “EBITDA”, “Adjusted EBITDA” and “Non-GAAP Adjusted Operating Expenses”, should not be considered in isolation or as a substitute for performance measures calculated in accordance with GAAP. In addition, these non-GAAP financial measures may differ from, and should not be compared to, similarly named measures used by other companies. The Company compensates for these limitations by relying primarily on its GAAP results and using Non-GAAP Net Loss, Non-GAAP net loss per basic and diluted share, EBITDA, Adjusted EBITDA, and Non-GAAP Adjusted Operating Expenses on a supplemental basis. You should review the reconciliation of the non-GAAP financial measures below and not rely on any single financial measure to evaluate the Company's business.
Management believes adjusted “Non-GAAP Net Loss”, “Non-GAAP net loss per basic and diluted share”, “EBITDA”, “Adjusted EBITDA” and “Non-GAAP Adjusted Operating Expenses” are useful to investors because they allow for comparison to the Company’s performance in prior periods without the effect of items that, by their nature, tend to obscure the Company’s core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. As a result, management believes that these measures enhance the ability of investors to analyze trends in the Company’s business and evaluate the Company’s performance relative to peer companies.
Reconciliations of the differences between these non-GAAP financial measures and their most directly comparable financial measures calculated in accordance with GAAP are set forth below.
The Company’s non-GAAP adjusted operating expenses are calculated by excluding stock-based compensation recorded in operating expenses. The Company’s non-GAAP EBITDA is calculated by excluding interest expense, provision (benefit) for income taxes, and depreciation and amortization. With respect to the Company’s 2026 financial guidance regarding non-GAAP adjusted operating expenses and non-GAAP EBITDA, the Company cannot provide a quantitative reconciliation to the most directly comparable GAAP measure without unreasonable effort due to its inability to make accurate projections and estimates related to certain information needed to calculate some of the adjustments as described above.
Velo3D, Inc.
Non-GAAP Net Loss Reconciliation
(Unaudited)
|
|
Three months ended |
|
|||||||||||||||||||||
|
|
March 31, 2026 |
|
|
December 31, 2025 |
|
|
March 31, 2025 |
|
|||||||||||||||
|
|
($ In thousands) |
|
|||||||||||||||||||||
|
|
% of Rev |
|
|
% of Rev |
|
|
% of Rev |
|
|||||||||||||||
Revenue |
|
$ |
13,816 |
|
|
|
100.0 |
% |
|
$ |
9,441 |
|
|
|
100.0 |
% |
|
$ |
9,320 |
|
|
|
100.0 |
% |
Gross profit (loss) |
|
|
2,381 |
|
|
|
17.2 |
% |
|
|
(6,946 |
) |
|
|
(73.6 |
)% |
|
|
697 |
|
|
|
7.5 |
% |
Net Loss |
|
$ |
(6,998 |
) |
|
|
(50.7 |
)% |
|
$ |
(21,897 |
) |
|
|
(231.9 |
)% |
|
$ |
(25,014 |
) |
|
|
(268.4 |
)% |
Stock-based compensation |
|
|
1,889 |
|
|
|
13.7 |
% |
|
|
2,175 |
|
|
|
23.0 |
% |
|
|
3,596 |
|
|
|
38.6 |
% |
Loss on warrant cancellation |
|
|
— |
|
|
|
— |
% |
|
|
— |
|
|
|
— |
% |
|
|
11,357 |
|
|
|
121.9 |
% |
Loss on fair value of warrants |
|
|
— |
|
|
|
— |
% |
|
|
96 |
|
|
|
1.0 |
% |
|
|
1,044 |
|
|
|
11.2 |
% |
Impairment of equipment subject to operating lease |
|
|
— |
|
|
|
— |
% |
|
|
1,066 |
|
|
|
11.3 |
% |
|
|
— |
|
|
|
— |
% |
Gain on fair value of contingent earnout liabilities |
|
|
— |
|
|
|
— |
% |
|
|
(10 |
) |
|
|
(0.1 |
)% |
|
|
— |
|
|
|
— |
% |
Non-routine inventory adjustment for excess and obsolete inventory |
|
|
— |
|
|
|
— |
% |
|
|
6,979 |
|
|
|
73.9 |
% |
|
|
— |
|
|
|
— |
% |
Non-GAAP Net Loss |
|
$ |
(5,109 |
) |
|
|
(37.0 |
)% |
|
$ |
(11,591 |
) |
|
|
(122.8 |
)% |
|
$ |
(9,017 |
) |
|
|
(96.7 |
)% |
Velo3D, Inc.
Non-GAAP Adjusted EBITDA Reconciliation
(Unaudited)
|
|
Three months ended |
|
|||||||||||||||||||||
|
|
March 31, 2026 |
|
|
December 31, 2025 |
|
|
March 31, 2025 |
|
|||||||||||||||
|
|
($ In thousands) |
|
|||||||||||||||||||||
|
|
% of Rev |
|
|
% of Rev |
|
|
% of Rev |
|
|||||||||||||||
Revenue |
|
$ |
13,816 |
|
|
|
100.0 |
% |
|
$ |
9,441 |
|
|
|
100.0 |
% |
|
$ |
9,320 |
|
|
|
100.0 |
% |
Net Loss |
|
|
(6,998 |
) |
|
|
(50.7 |
)% |
|
|
(21,897 |
) |
|
|
(231.9 |
)% |
|
|
(25,014 |
) |
|
|
(268.4 |
)% |
Interest expense |
|
|
733 |
|
|
|
5.3 |
% |
|
|
524 |
|
|
|
5.6 |
% |
|
|
1,070 |
|
|
|
11.5 |
% |
Provision (benefit) for income taxes |
|
|
26 |
|
|
|
0.2 |
% |
|
|
34 |
|
|
|
0.4 |
% |
|
|
8 |
|
|
|
0.1 |
% |
Depreciation and amortization |
|
|
762 |
|
|
|
5.5 |
% |
|
|
1,026 |
|
|
|
10.9 |
% |
|
|
995 |
|
|
|
10.7 |
% |
EBITDA |
|
$ |
(5,477 |
) |
|
|
(39.6 |
)% |
|
$ |
(20,313 |
) |
|
|
(215.2 |
)% |
|
$ |
(22,941 |
) |
|
|
(246.1 |
)% |
Stock-based compensation |
|
|
1,889 |
|
|
|
13.7 |
% |
|
|
2,175 |
|
|
|
23.0 |
% |
|
|
3,596 |
|
|
|
38.6 |
% |
Loss on warrant cancellation |
|
|
— |
|
|
|
— |
% |
|
|
— |
|
|
|
— |
% |
|
|
11,357 |
|
|
|
121.9 |
% |
Loss on fair value of warrants |
|
|
— |
|
|
|
— |
% |
|
|
96 |
|
|
|
1.0 |
% |
|
|
1,044 |
|
|
|
11.2 |
% |
Impairment of equipment subject to operating lease |
|
|
— |
|
|
|
— |
% |
|
|
1,066 |
|
|
|
11.3 |
% |
|
|
— |
|
|
|
— |
% |
Gain on fair value of contingent earnout liabilities |
|
|
— |
|
|
|
— |
% |
|
|
(10 |
) |
|
|
(0.1 |
)% |
|
|
— |
|
|
|
— |
% |
Non-routine inventory adjustment for excess and obsolete inventory |
|
|
— |
|
|
|
— |
% |
|
|
6,979 |
|
|
|
73.9 |
% |
|
|
— |
|
|
|
— |
% |
Non-GAAP Adjusted EBITDA |
|
$ |
(3,588 |
) |
|
|
(26.0 |
)% |
|
$ |
(10,007 |
) |
|
|
(106.0 |
)% |
|
$ |
(6,944 |
) |
|
|
(74.5 |
)% |
Velo3D, Inc.
Non-GAAP Adjusted Operating Expenses Reconciliation
(Unaudited)
|
|
Three months ended |
|
|||||||||||||||||||||
|
|
March 31, 2026 |
|
|
December 31, 2025 |
|
|
March 31, 2025 |
|
|||||||||||||||
|
|
($ In thousands) |
|
|||||||||||||||||||||
|
|
% of Rev |
|
|
% of Rev |
|
|
% of Rev |
|
|||||||||||||||
Revenue |
|
$ |
13,816 |
|
|
|
100.0 |
% |
|
$ |
9,441 |
|
|
|
100.0 |
% |
|
$ |
9,320 |
|
|
|
100.0 |
% |
Operating expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Research and development |
|
|
2,695 |
|
|
|
19.5 |
% |
|
|
3,283 |
|
|
|
34.8 |
% |
|
|
2,059 |
|
|
|
22.1 |
% |
Selling and marketing |
|
|
1,721 |
|
|
|
12.5 |
% |
|
|
2,415 |
|
|
|
25.6 |
% |
|
|
1,086 |
|
|
|
11.7 |
% |
General and administrative |
|
|
4,912 |
|
|
|
35.6 |
% |
|
|
9,163 |
|
|
|
97.1 |
% |
|
|
9,076 |
|
|
|
97.4 |
% |
Total operating expenses |
|
$ |
9,328 |
|
|
|
67.5 |
% |
|
$ |
14,861 |
|
|
|
157.4 |
% |
|
$ |
12,221 |
|
|
|
131.1 |
% |
Stock-based compensation recorded in operating expenses |
|
|
1,246 |
|
|
|
9.0 |
% |
|
|
1,533 |
|
|
|
16.2 |
% |
|
|
3,387 |
|
|
|
36.3 |
% |
Non-GAAP Adjusted operating expenses |
|
$ |
8,082 |
|
|
|
58.5 |
% |
|
$ |
13,328 |
|
|
|
141.2 |
% |
|
$ |
8,834 |
|
|
|
94.8 |
% |
Velo3D, Inc.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
(In thousands, except share and per share data)
|
|
The three months ended March 31, |
|
|||||
|
|
2026 |
|
|
2025 |
|
||
Revenue |
|
|
|
|
|
|
||
3D Printer and parts |
|
$ |
12,021 |
|
|
$ |
7,523 |
|
Recurring payment |
|
|
— |
|
|
|
— |
|
Support services |
|
|
1,269 |
|
|
|
1,790 |
|
Other |
|
|
526 |
|
|
|
7 |
|
Total Revenue |
|
|
13,816 |
|
|
|
9,320 |
|
Cost of revenue |
|
|
|
|
|
|
||
3D Printer and parts |
|
|
10,225 |
|
|
|
7,540 |
|
Recurring payment |
|
|
— |
|
|
|
12 |
|
Support services |
|
|
1,210 |
|
|
|
1,071 |
|
Total cost of revenue |
|
|
11,435 |
|
|
|
8,623 |
|
Gross profit |
|
|
2,381 |
|
|
|
697 |
|
Operating expenses |
|
|
|
|
|
|
||
Research and development |
|
|
2,695 |
|
|
|
2,059 |
|
Selling and marketing |
|
|
1,721 |
|
|
|
1,086 |
|
General and administrative |
|
|
4,912 |
|
|
|
9,076 |
|
Total operating expenses |
|
|
9,328 |
|
|
|
12,221 |
|
Loss from operations |
|
|
(6,947 |
) |
|
|
(11,524 |
) |
Interest expense |
|
|
(733 |
) |
|
|
(1,070 |
) |
Loss on fair value of warrants |
|
|
— |
|
|
|
(1,044 |
) |
Loss on warrant cancellation |
|
|
— |
|
|
|
(11,357 |
) |
Other income (expense), net |
|
|
708 |
|
|
|
(11 |
) |
Loss before income taxes |
|
|
(6,972 |
) |
|
|
(25,006 |
) |
Provision for income taxes |
|
|
(26 |
) |
|
|
(8 |
) |
Net loss |
|
$ |
(6,998 |
) |
|
$ |
(25,014 |
) |
|
|
|
|
|
|
|
||
Net loss per share: |
|
|
|
|
|
|
||
Basic and Diluted |
|
$ |
(0.28 |
) |
|
$ |
(1.87 |
) |
Shares used in computing net loss per share: |
|
|
|
|
|
|
||
Basic and Diluted |
|
|
25,021,065 |
|
|
|
13,398,104 |
|
Velo3D, Inc.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
(In thousands, except share and per share data)
|
|
March 31, |
|
|
December 31, |
|
||
|
|
2026 |
|
|
2025 |
|
||
Assets |
|
|
|
|
|
|
||
Current assets: |
|
|
|
|
|
|
||
Cash and cash equivalents |
|
$ |
16,564 |
|
|
$ |
39,013 |
|
Accounts receivable, net |
|
|
6,732 |
|
|
|
6,263 |
|
Inventories, net |
|
|
28,104 |
|
|
|
27,083 |
|
Contract assets |
|
|
4,120 |
|
|
|
2,039 |
|
Prepaid expenses and other current assets |
|
|
9,650 |
|
|
|
5,722 |
|
Total current assets |
|
|
65,170 |
|
|
|
80,120 |
|
Property and equipment, net |
|
|
16,387 |
|
|
|
13,094 |
|
Equipment subject to operating lease, net |
|
|
1,054 |
|
|
|
1,629 |
|
Other assets |
|
|
9,793 |
|
|
|
10,505 |
|
Total assets |
|
$ |
92,404 |
|
|
$ |
105,348 |
|
Liabilities and Stockholders’ Equity |
|
|
|
|
|
|
||
Current liabilities: |
|
|
|
|
|
|
||
Accounts payable |
|
$ |
9,089 |
|
|
$ |
10,301 |
|
Accrued expenses and other current liabilities |
|
|
6,655 |
|
|
|
7,915 |
|
Debt – current portion |
|
|
3,135 |
|
|
|
6,305 |
|
Contract liabilities |
|
|
7,739 |
|
|
|
9,281 |
|
Total current liabilities |
|
|
26,618 |
|
|
|
33,802 |
|
Long-term debt – less current portion |
|
|
6,037 |
|
|
|
24,710 |
|
Contingent earnout liabilities |
|
|
1 |
|
|
|
1 |
|
Warrant liabilities |
|
|
109 |
|
|
|
109 |
|
Other noncurrent liabilities |
|
|
8,099 |
|
|
|
8,570 |
|
Total liabilities |
|
|
40,864 |
|
|
|
67,192 |
|
|
|
|
|
|
|
|
||
Stockholders’ equity: |
|
|
|
|
|
|
||
Common stock, $0.00001 par value – 500,000,000 shares authorized at March 31, 2026 and December 31, 2025, 26,216,822 and 24,607,630 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively |
|
|
5 |
|
|
|
5 |
|
Additional paid-in capital |
|
|
556,676 |
|
|
|
536,294 |
|
Accumulated deficit |
|
|
(505,141 |
) |
|
|
(498,143 |
) |
Total stockholders’ equity |
|
|
51,540 |
|
|
|
38,156 |
|
Total liabilities and stockholders’ equity |
|
$ |
92,404 |
|
|
$ |
105,348 |
|
Velo3D, Inc.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(In thousands)
|
|
The three months ended March 31, |
|
|||||
|
|
2026 |
|
|
2025 |
|
||
Cash flows from operating activities |
|
|
|
|
|
|
||
Net loss |
|
$ |
(6,998 |
) |
|
$ |
(25,014 |
) |
Adjustments to reconcile net loss to net cash used in operating activities |
|
|
|
|
|
|
||
Depreciation and amortization |
|
|
762 |
|
|
|
995 |
|
Amortization of debt discount and deferred financing costs |
|
|
17 |
|
|
|
48 |
|
Stock-based compensation |
|
|
1,889 |
|
|
|
3,596 |
|
Loss on fair value of warrants |
|
|
— |
|
|
|
1,044 |
|
Loss on warrant cancellation |
|
|
— |
|
|
|
11,357 |
|
Non-cash lease expense |
|
|
59 |
|
|
|
28 |
|
Changes in operating assets and liabilities |
|
|
|
|
|
|
||
Accounts receivable |
|
|
(469 |
) |
|
|
(846 |
) |
Inventories |
|
|
672 |
|
|
|
1,989 |
|
Contract assets |
|
|
(2,081 |
) |
|
|
(795 |
) |
Prepaid expenses and other current assets |
|
|
(3,928 |
) |
|
|
(3,407 |
) |
Other assets |
|
|
648 |
|
|
|
1,224 |
|
Accounts payable |
|
|
(5,504 |
) |
|
|
(860 |
) |
Accrued expenses and other liabilities |
|
|
(1,032 |
) |
|
|
1,195 |
|
Contract liabilities |
|
|
(1,542 |
) |
|
|
(2,671 |
) |
Other noncurrent liabilities |
|
|
(471 |
) |
|
|
(232 |
) |
Net cash used in operating activities |
|
|
(17,978 |
) |
|
|
(12,349 |
) |
Cash flows from investing activities |
|
|
|
|
|
|
||
Purchase of property and equipment |
|
|
(940 |
) |
|
|
— |
|
Net cash used in investing activities |
|
|
(940 |
) |
|
|
— |
|
Cash flows from financing activities |
|
|
|
|
|
|
||
Proceeds from convertible secured notes |
|
|
— |
|
|
|
15,000 |
|
Repayment of 2025 equipment loan |
|
|
(496 |
) |
|
|
— |
|
Repayment of secured notes |
|
|
(3,039 |
) |
|
|
— |
|
Net cash (used in) provided by financing activities |
|
|
(3,535 |
) |
|
|
15,000 |
|
Effect of exchange rate changes on cash and cash equivalents |
|
|
(1 |
) |
|
|
7 |
|
Net change in cash and cash equivalents |
|
|
(22,454 |
) |
|
|
2,658 |
|
Cash and cash equivalents and restricted cash at beginning of period |
|
|
39,641 |
|
|
|
1,840 |
|
Cash and cash equivalents and restricted cash at end of period |
|
$ |
17,187 |
|
|
$ |
4,498 |
|
The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets to the total of such amounts shown on the condensed consolidated statements of cash flows:
|
|
The three months ended March 31, |
|
|||||
|
|
2026 |
|
|
2025 |
|
||
Cash and cash equivalents |
|
$ |
16,564 |
|
|
$ |
3,870 |
|
Restricted cash (Other assets) |
|
|
623 |
|
|
|
628 |
|
Total cash and cash equivalents and restricted cash |
|
$ |
17,187 |
|
|
$ |
4,498 |
|
First Quarter 2026 Supplementary Slides May 12, 2026
Confidential & Proprietary | Disclaimer Forward Looking Statement This presentation includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. The Company’s actual results may differ from its expectations, estimates and projections and consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect”, “estimate”, “project”, “budget”, “forecast”, “anticipate”, “intend”, “plan”, “may”, “will”, “could”, “should”, “believes”, “predicts”, “potential”, “continue”, and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, the Company's guidance for fiscal year 2026 (including the Company’s estimates for revenue, gross margin, operating expenses, and capital expenditures), the Company’s expectations regarding its ability to achieve positive EBITDA in the second half of 2026, the Company’s expectations about future demand, growth, profitability, long-term value, capacity requirements and operational efficiencies, scaled production, pipeline of opportunities, customer priorities, positive gross margins, the Company’s expectations regarding its liquidity and capital requirements, including plans to raise additional capital to support its expansion and the potential sources and uses of that capital, the Company’s expectations regarding its potential cost savings, the Company’s expectations about its market strategy and financial and operational position, the Company's expectations that the RPS parts production business will contribute an increasing share of revenue, and the Company’s other expectations, beliefs, intentions or strategies for the future. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. You should carefully consider the risks and uncertainties described in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the “FY 2025 10-K”) and its Quarterly Reports on Form 10-Q ("Quarterly Reports") and the other documents filed by the Company from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Most of these factors are outside the Company’s control and are difficult to predict. Factors that may cause such differences include, but are not limited to: (1) the inability of the Company to execute its business plan, which may be affected by, among other things, competition, the Company’s liquidity position/lack of available cash, the ability of the Company to grow and manage growth profitably, maintain relationships with customers and suppliers and retain its key employees; (2) the Company’s ability to continue as a going concern; (3) the Company’s ability to service and comply with its indebtedness; (4) the Company’s ability to raise additional capital in the near-term; (5) the possibility that the Company may be adversely affected by other economic, business, and/or competitive factors; (6) changes in the applicable laws and regulations; (7) risks related to the Company’s exposure to government and defense contracts, including potential delays or reductions in government funding, government shutdowns, changes in defense procurement priorities or spending levels, and the timing and uncertainty of government contract awards and modifications; and (8) other risks and uncertainties described in the FY 2025 10-K and the Quarterly Reports, including those under “Risk Factors” therein, and in the Company’s other filings with the SEC. The Company cautions that the foregoing list of factors is not exclusive and not to place undue reliance upon any forward-looking statements, including projections, which speak only as of the date made. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by applicable law. * Additional information on the use of Non-GAAP financial information, industry and market data, and trademarks is included in the appendix of this presentation.
Strong Q1 pipeline momentum driven by our refined go-to-market model and Defense opportunities RPS Momentum Drives Q1 Pipeline Growth Repeat Customers Continue to Drive Demand While Adding New Customers Defense Pipeline Generation Repeat orders have been consistently in the 70%+ range of total orders Defense sector makes up majority of part pipeline created in Q1 Total Backlog* * $ in millions Backlog remained near prior quarter (Q4 2025) levels
Velo3D: Awarded $9.8 Million Five-Year IDIQ Contract by Department of War Supports Defense Logistics Agency JAMA Pilot Parts Program to accelerate additive manufacturing adoption Establishes flexible, rapid procurement pathway for 3D-printed components across all military branches Deploys industrial-scale Laser Powder Bed Fusion (LPBF) and Rapid Production Solution (RPS) capabilities Targets hard-to-source parts with long lead times, obsolescence, or limited domestic supply Advances supply chain resilience, readiness and distributed manufacturing Enables faster delivery of mission-critical spare and replacement parts Supports qualification-to-production lifecycle, including surge manufacturing capacity U.S.-built Sapphire® printers enable large, high-fidelity part production with consistent quality and in-situ monitoring
Confidential & Proprietary | Financial Overview
Financial Summary Reconciliations to U.S. generally accepted accounting principles (GAAP) financial measures are presented under “Non-GAAP Financial Information.” Non-GAAP Operating Expenses excludes stock-based compensation. Non-GAAP Adjusted EBITDA excludes interest expense, tax expense, depreciation and amortization, stock-based compensation, loss on warrant cancellation, fair value adjustments, impairment on equipment subject to operating lease, and non-recurring inventory adjustment. ($ in millions) Q1’26 Q4’25 Q1’25 Total Revenue $13.8 $9.4 $9.3 3D Printer and Parts Sales 12.0 7.6 7.5 Support Service / License / Recurring Revenue 1.8 1.8 1.8 Cost of Goods sold 11.4 16.4 8.6 Gross Profit 2.4 ($6.9) 0.7 % Gross Margin 17.2% (73.6%) 7.5% Total Operating Expenses 9.3 14.9 12.2 Non-GAAP Adjusted Operating Expenses1 8.1 13.3 8.8 Net Income (Loss) (7.0) ($21.9) ($25.0) Non-GAAP Adjusted EBITDA1 (3.6) (10.0) (6.9)
2023 Outlook * Q423 / FY 2023 gross margin ranges excludes impact from non-recurring charges 2026 Outlook FY 2026 Guidance as of May 12, 2026 • Revenue in the range of $60 million to $70 million • Sequential improvement in gross margin o Greater than 30% gross margin in second half of 2026 • Non-GAAP adjusted operating expenses in the range of $45 million to $55 million • Capital expenditures in the range of $40 million to $50 million, primarily for RPS expansion, subject to the availability of sufficient financing • Positive EBITDA in the second half of 2026 * The Company has not provided a reconciliation of non-GAAP adjusted operating expense and EBITDA guidance measures to the most directly comparable GAAP measures because certain items excluded from GAAP cannot be reasonably calculated or predicted at this time. Accordingly, a reconciliation is not available without unreasonable effort.
Thank You!
Disclaimer Non-GAAP Financial Information The Company uses non-GAAP financial measures, such as Non-GAAP / Adjusted operating expenses, EBITDA, Adjusted EBITDA, and Non-GAAP net (loss), to help it make strategic decisions, establish budgets and operational goals for managing its business, analyze its financial results and evaluate its performance. Management believes adjusted “Non-GAAP Net Loss”, “Non-GAAP net loss per basic and diluted share”, “EBITDA”, “Adjusted EBITDA” and “Non-GAAP Adjusted Operating Expenses” are useful to investors because they allow for comparison to the Company’s performance in prior periods without the effect of items that, by their nature, tend to obscure the Company’s core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. As a result, management believes that these measures enhance the ability of investors to analyze trends in the Company’s business and evaluate the Company’s performance relative to peer companies. Industry and Market Data In this presentation, the Company relies on and refers to publicly available information and statistics regarding the market in which the Company competes and other industry data. The Company obtained this information and statistics from third-party sources, including reports by market research firms and company filings. While the Company believes such third-party information is reliable, there can be no assurance as to the accuracy or completeness of the indicated information. The Company has not independently verified the information provided by third-party sources. Trademarks This presentation may contain trademarks, service marks, trade names and copyrights of other companies, which are the property of the respective owners. Solely for convenience, some of the trademarks, service marks, trade names and copyrights referred to in this presentation may be listed without the TM, SM, © or ® symbols, but the Company will assert, to the fullest extent under applicable law, the rights of the applicable owners, if any, to these trademarks, service marks, trade names and copyrights.
Non-GAAP Reconciliation - Non-GAAP Net Loss (Unaudited) Confidential & Proprietary |
Non-GAAP Reconciliation - Adjusted EBITDA (Unaudited) Confidential & Proprietary |
Non-GAAP Reconciliation - Non-GAAP Adjusted Operating Expenses (Unaudited) Confidential & Proprietary |